Neurosymbolic AI in Healthcare

Abstract

Artificial intelligence (AI) in healthcare stands at a critical juncture. Although deep learning has achieved remarkable pattern-recognition capabilities, its opacity and brittleness limit clinical adoption in high-stakes medical settings. Neurosymbolic AI, which integrates the perceptual power of neural networks with the logical reasoning of symbolic systems, offers a synthesis that addresses these fundamental limitations. This article traces the evolution of medical AI from early expert systems, through the deep learning revolution, to the emerging neurosymbolic paradigm. We examine core architectural principles; survey clinical applications in diagnostic decision support, oncology information extraction, and clinical trial recruitment; analyze key technical and regulatory challenges; and outline a strategic research agenda. The neurosymbolic approach promises systems that are simultaneously high-performing and clinically auditable, transparent and adaptive, and data-efficient and robust: qualities essential for the next generation of trustworthy medical AI.

Keywords: Neurosymbolic AI, Healthcare, Explainable AI, Knowledge Graphs, Clinical Decision Support, Medical Intelligence, Expert Systems

1Introduction: The Quest for Intelligent, Trustworthy Medical AI

Consider an artificial intelligence (AI) system that analyzes a chest radiograph and reports, with 95% confidence, that the patient has pneumonia. The physician asks why. The system cannot answer: it has detected patterns across millions of pixels, but it cannot articulate what it saw, relate those findings to medical knowledge, or justify its conclusion in clinical terms. Would you trust that diagnosis with your life?

This scenario captures the central challenge for AI in medicine. Modern deep learning has achieved extraordinary feats: detecting cancers that human readers can miss [1], predicting the deterioration of patients in intensive care hours before a crisis [2], and triaging pathology slides so that specialists can focus on the cases that need them [3]. Yet these systems remain fundamentally pattern-matching engines rather than reasoning systems. They cannot explain their logic, incorporate clinical guidelines, or clarify why they reached a conclusion.

In medicine, unexplained recommendations can cost lives. When an AI system proposes a treatment, physicians must understand its reasoning, not only to verify its accuracy but also to identify contraindications and integrate the recommendation with their own clinical judgment. As regulation tightens and liability grows, transparency is no longer optional; it is foundational.

The core problem is architectural. Deep learning systems encode knowledge in millions to billions of numerical parameters: abstract patterns that excel at classification but resist translation into human concepts. Medicine, by contrast, expresses knowledge as relationships: “pneumonia causes consolidation on chest radiographs,” “fever plus rash suggests a viral infection,” “this drug is contraindicated in that condition.” Current deep learning systems cannot bridge this representational divide.

Neurosymbolic AI is a paradigm that unites the perceptual power of neural networks with the logical clarity of symbolic reasoning. These hybrid architectures do not merely predict; they explain. For clinicians, healthcare administrators, and AI researchers, understanding how neurosymbolic systems can improve decision-making while satisfying stringent safety and interpretability requirements is increasingly important. This article provides a comprehensive examination of neurosymbolic AI in healthcare, tracing its evolution from historical foundations through current capabilities to future transformation.

2Historical Context: From MYCIN to Modern Synthesis

2.1The Era of Expert Systems

Medical AI began with symbolic approaches that sought to capture human expertise in formal logical structures. In the 1970s, systems such as MYCIN pioneered rule-based clinical decision support, encoding expert knowledge as explicit if-then rules [4, 5]. MYCIN could diagnose bacterial infections and recommend antibiotics through transparent reasoning chains that physicians could audit and validate: a glass box in an era before the black box had become a concern [6].

These early expert systems offered remarkable interpretability and medical soundness, but they suffered from critical limitations that contributed to the AI winter of the late 1980s. They were brittle when confronted with cases outside their rule sets, required costly knowledge engineering with constant manual updates, and could neither learn from data nor handle uncertainty gracefully. As medical knowledge expanded rapidly, maintaining comprehensive rule bases became unsustainable, exposing a fundamental flaw of the purely symbolic paradigm.

McCarthy’s now-famous cholera thought experiment illustrates this brittleness. Told that a patient had Vibrio cholerae in the intestines, MYCIN would “cheerfully recommend two weeks of tetracycline and nothing else” [6], without addressing the diarrhea and dehydration that would likely kill the patient long before the antibiotic took effect. This failure to account for clinical context showed that transparency without adaptability is insufficient for medical practice.

2.2The Deep Learning Revolution and Its Discontents

The 2010s brought a paradigm shift that appeared to resolve the limitations of symbolic systems. Deep learning transformed medical imaging, achieving expert-level performance in detecting diabetic retinopathy [7], classifying skin lesions [8], and identifying pneumonia on chest radiographs [9]. Neural networks could learn directly from data without manual feature engineering, scale to millions of examples, and adapt to new patterns automatically.

Yet this power came with profound trade-offs that created new obstacles to clinical adoption. Deep models became black boxes: their learned representations were opaque, their decisions unexplained, and their failures unpredictable. They required massive labeled datasets, struggled under distribution shift, and lacked mechanisms for encoding domain knowledge or performing causal reasoning. For high-stakes clinical decisions, these limitations proved problematic [10, 11], creating a new kind of trust gap: fear of the unknown unknowns inside an opaque system.

2.3The Two Paradigms Compared

Symbolic AI

Symbolic AI, founded on the hypothesis that intelligence can be achieved by manipulating symbols according to formal rules [12, 13], offers inherent explainability and verifiability [14]. Its reasoning follows a discrete, logical path, making decisions auditable and accountable [15]. However, such systems are notoriously brittle and inflexible [6]. They struggle to process noisy, unstructured data, and their knowledge is static: updating them requires painstaking, unscalable manual encoding by human experts, a problem known as the knowledge acquisition bottleneck [14].

Deep Learning

Deep learning uses multilayer artificial neural networks to learn hierarchical patterns directly from large quantities of data [16, 17]. This approach has achieved expert-level performance across a wide range of pattern-recognition tasks, from radiological image analysis to genomic analysis [18].

The principal weakness of deep learning is the well-known black-box problem: the decision-making process of these models is opaque and difficult to interpret [19], which creates a fundamental barrier to trust in clinical practice [10]. Furthermore, as purely statistical pattern matchers, generative models in particular are prone to generating plausible but factually incorrect outputs, a phenomenon known as hallucination [20, 21].

What was needed was a third way: an approach capable of bridging this divide. Table 1 contrasts the two paradigms.

Table 1. The two paradigms of AI: a comparative analysis.

Feature: Core principle
Symbolic AI: Intelligence as symbol manipulation according to formal rules.
Deep learning: Intelligence as pattern recognition learned from data.

Feature: Data handling
Symbolic AI: Excels with structured, explicit knowledge (e.g., ontologies, rule bases); struggles with noisy, unstructured data.
Deep learning: Excels with large, unstructured datasets (e.g., images, text, sensor data).

Feature: Learning capability
Symbolic AI: Limited or absent; knowledge must be encoded manually by experts.
Deep learning: Core strength; learns and adapts from experience and new data.

Feature: Explainability
Symbolic AI: High; the decision-making process is transparent and auditable through logical rules.
Deep learning: Low (black box); internal decision-making is opaque and difficult to interpret.

Feature: Reasoning
Symbolic AI: Strong deductive and logical reasoning over its knowledge base.
Deep learning: Weak; primarily statistical inference and pattern matching rather than logical deduction.

Feature: Key weakness
Symbolic AI: Brittleness: fails in situations outside its predefined rules; inflexible and difficult to scale.
Deep learning: Opacity and unreliability: lacks interpretability and can hallucinate, generating plausible but false information.

Feature: Medical analogy
Symbolic AI: A comprehensive but rigid textbook that cannot be updated and has no understanding of clinical context beyond its text.
Deep learning: A medical resident with a photographic memory of every case they have seen but no understanding of the underlying medical principles or clinical guidelines.

Feature	Symbolic AI	Deep learning
Core principle	Intelligence as symbol manipulation according to formal rules.	Intelligence as pattern recognition learned from data.
Data handling	Excels with structured, explicit knowledge (e.g., ontologies, rule bases); struggles with noisy, unstructured data.	Excels with large, unstructured datasets (e.g., images, text, sensor data).
Learning capability	Limited or absent; knowledge must be encoded manually by experts.	Core strength; learns and adapts from experience and new data.
Explainability	High; the decision-making process is transparent and auditable through logical rules.	Low (black box); internal decision-making is opaque and difficult to interpret.
Reasoning	Strong deductive and logical reasoning over its knowledge base.	Weak; primarily statistical inference and pattern matching rather than logical deduction.
Key weakness	Brittleness: fails in situations outside its predefined rules; inflexible and difficult to scale.	Opacity and unreliability: lacks interpretability and can hallucinate, generating plausible but false information.
Medical analogy	A comprehensive but rigid textbook that cannot be updated and has no understanding of clinical context beyond its text.	A medical resident with a photographic memory of every case they have seen but no understanding of the underlying medical principles or clinical guidelines.

2.4Toward Integration: The Neurosymbolic Vision

It became increasingly clear that neither purely symbolic nor purely neural approaches could meet the complexity of medical practice. Medicine demands both perceptual sophistication and logical rigor, both learning from data and reasoning with knowledge, both pattern recognition and causal understanding. Neurosymbolic AI emerged as a synthesis that addresses these dual requirements [22].

The neurosymbolic vision combines complementary strengths: neural networks handle perception, uncertainty, and pattern discovery, while symbolic systems provide structure, interpretability, and knowledge integration. Together, they promise systems that think like physicians: transparently, adaptively, and reliably. This represents the so-called third wave of AI, a deliberate synthesis designed to overcome the fundamental limitations of both preceding paradigms.

The clinical trust gap that affects medical AI today therefore has two faces: fear of the unknown unknowns in an opaque black box (deep learning), and fear of known but ignored context in a transparent glass box (symbolic AI). Neurosymbolic AI aims to build systems that are both powerful and principled, establishing the foundation of trust required for safe and effective deployment in high-stakes medical applications.

3The Neurosymbolic Paradigm: Teaching AI to Think like Physicians

The central ambition of neurosymbolic AI (NeSy) is to create a “best of both worlds” system that can learn from data while reasoning with explicit knowledge [22].

3.1Foundational Principles

Training a medical student involves more than showing thousands of radiographs. Educators teach anatomy, physiology, and diagnostic logic. They explain why pneumonia appears white (opaque) on a chest radiograph (fluid-filled air spaces increase tissue density) and how to interpret findings in context. Human clinicians integrate perceptual recognition with structured knowledge; neurosymbolic AI does the same [22].

At its core, a neurosymbolic system combines three components [22]:

A neural model $f_\theta(x)$ that learns patterns from data, identifying features in images, risk factors in health records, or disease signatures in laboratory results.
A symbolic model $R = \{r_1, r_2, \ldots, r_n\}$ that encodes explicit medical knowledge: practice guidelines, contraindication rules, and causal relations.
An integration mechanism that ensures both components operate coherently, through joint learning or sequential processing.

A common formulation trains these components together through a composite learning objective:

\mathcal{L}_{\text{total}} = \mathcal{L}_{\text{neural}}\big(f_\theta(x),\, y\big) + \lambda\, \mathcal{L}_{\text{symbolic}}\big(\Phi(f_\theta(x)),\, R\big)

where $\mathcal{L}_{\text{neural}}$ is a standard supervised loss between the model’s predictions and the labels $y$ , $\Phi$ maps neural outputs to symbolic assertions, $\mathcal{L}_{\text{symbolic}}$ penalizes violations of the rules in $R$ , and $\lambda \geq 0$ balances empirical learning against medical consistency [22]. For example, if the network predicts a low probability of viral infection despite fever, rash, and known exposure, the symbolic loss increases, signaling a violation of medical logic. During training, the system thus learns to align data-driven patterns with clinical reasoning, producing predictions that are both accurate and medically coherent.

This framework draws inspiration from the dual-process theory popularized by Daniel Kahneman in Thinking, Fast and Slow [23, 24]. The neural component plays the role of System 1 (fast, intuitive pattern recognition), while the symbolic component plays the role of System 2 (deliberate, rule-based reasoning). Together, they yield systems that think like physicians, combining rapid perceptual insight with careful logical analysis.

3.2Architectural Paradigms

Neurosymbolic systems can be organized along several complementary design axes, each offering distinct advantages for different clinical applications:

Neural-guided symbolic reasoning. Neural modules extract structured semantic representations from raw clinical data (images, signals, notes), which symbolic reasoning engines then process using formal logic or ontological inference. This leverages the pattern recognition of deep learning while retaining the interpretability of symbolic methods.
Symbolically constrained learning. Symbolic domain knowledge (medical ontologies, physiological constraints, clinical guidelines) serves as an inductive bias during neural network training or as explicit regularization. This can substantially improve data efficiency and prevent physiologically implausible predictions.
Hybrid end-to-end architectures. These systems interleave neural components with differentiable approximations of symbolic operations (soft logic layers, differentiable theorem provers), enabling joint gradient-based optimization while preserving interpretability.
Program synthesis. Neural networks generate, select, or parameterize symbolic programs (diagnostic workflows, treatment protocols, database queries) that execute deterministically. This combines the flexibility of learned program structure with the reliability of symbolic execution.

Each paradigm addresses a different aspect of the medical AI challenge. Neural-guided symbolic reasoning excels at complex diagnostic workflows; symbolically constrained learning guards against dangerous hallucinations in high-stakes scenarios; hybrid architectures enable end-to-end optimization for specific clinical tasks; and program synthesis yields adaptive yet reliable treatment protocols. Figure 1 summarizes the resulting pipeline, and Table 2 summarizes selected architecture types from Kautz’s taxonomy [24].

Raw medical dataImages, health records, sensors

Neural model

f_\theta(x)

Learns patterns from data

Symbolic knowledge

R

Rules, ontologies

Integration layer

\Phi\big(f_\theta(x)\big)

Grounds predictions in interpretable concepts and enforces medical constraints

Explainable clinical outputPredictions + justifications

Figure 1. The neurosymbolic pipeline for healthcare. Neural components extract patterns from complex inputs; symbolic components encode structured medical expertise and constrain the neural model; and the integration layer grounds predictions in interpretable concepts while enforcing medical constraints, transforming raw medical data into transparent, trustworthy outputs.

Table 2. Selected neurosymbolic architecture types. Notation follows Kautz [24].

Architecture type: Neuro | Symbolic
Description: A neural network processes raw data to extract symbols, which a separate symbolic reasoner then processes.
Medical analogy: A junior resident (neural network) reads a complex patient chart and summarizes the key findings (symbols); an attending physician (symbolic reasoner) then applies clinical guidelines to reach a final decision.

Architecture type: Symbolic[Neuro]
Description: A high-level symbolic algorithm (e.g., a planner or search procedure) calls a neural network as a subroutine to evaluate specific options.
Medical analogy: Surgical planning software (symbolic) simulates thousands of candidate incision paths, using a neural network at each step to predict the risk of nerve damage along that path.

Architecture type: Neuro[Symbolic]
Description: A primary neural model calls an external symbolic tool to perform a specialized, precise task such as a calculation or a database query.
Medical analogy: An AI clinical assistant (neural network) conversing with a physician recognizes the need to calculate a patient’s body mass index (BMI) and calls a simple, reliable calculator function (symbolic) to obtain the exact value.

Architecture type: Symbolically constrained learning (Neuro_Symbolic)
Description: Symbolic rules are incorporated into the neural network’s training process as guardrails to ensure that its outputs are logically consistent with known facts.
Medical analogy: Training a medical student whose grade is penalized not only for wrong answers but also for answers that violate fundamental biological principles (e.g., prescribing an antibiotic for a viral infection), even when such answers seem statistically plausible based on past exams.

Architecture type	Description	Medical analogy
Neuro \| Symbolic	A neural network processes raw data to extract symbols, which a separate symbolic reasoner then processes.	A junior resident (neural network) reads a complex patient chart and summarizes the key findings (symbols); an attending physician (symbolic reasoner) then applies clinical guidelines to reach a final decision.
Symbolic[Neuro]	A high-level symbolic algorithm (e.g., a planner or search procedure) calls a neural network as a subroutine to evaluate specific options.	Surgical planning software (symbolic) simulates thousands of candidate incision paths, using a neural network at each step to predict the risk of nerve damage along that path.
Neuro[Symbolic]	A primary neural model calls an external symbolic tool to perform a specialized, precise task such as a calculation or a database query.	An AI clinical assistant (neural network) conversing with a physician recognizes the need to calculate a patient’s body mass index (BMI) and calls a simple, reliable calculator function (symbolic) to obtain the exact value.
Symbolically constrained learning (Neuro_Symbolic)	Symbolic rules are incorporated into the neural network’s training process as guardrails to ensure that its outputs are logically consistent with known facts.	Training a medical student whose grade is penalized not only for wrong answers but also for answers that violate fundamental biological principles (e.g., prescribing an antibiotic for a viral infection), even when such answers seem statistically plausible based on past exams.

4Present State: Clinical Applications and Current Capabilities

While the theoretical promise of neurosymbolic AI is compelling, its true value is demonstrated by its application to real-world clinical and research problems. A growing number of studies of NeSy systems now report quantifiable performance improvements over both traditional machine learning and purely neural approaches.

4.1Precision Diagnostics and Decision Support

Neurosymbolic models address the black-box problem directly: they are designed to be both accurate and inherently explainable.

The application of Logical Neural Networks (LNNs) to diabetes prediction is a representative example [25]. LNN-based models integrate logical rules with neural components. In one study, the best-performing LNN model achieved an accuracy of 80.52%, outperforming the strongest traditional machine learning baseline, a random forest (76.95%) [25]. Critically, the model remained transparent, providing direct, quantifiable insight into the contribution of individual risk factors (e.g., glucose level, body mass index) to the final prediction [25].

In oncology research, the Neuro-Symbolic System for Cancer (NSSC) automates the extraction and structuring of terms from physicians’ free-text notes [26]. It uses a BERT-based neural component for named entity recognition, followed by a symbolic reasoning system that links the recognized entities to a formal medical knowledge base, the Unified Medical Language System (UMLS), ensuring contextual disambiguation [26]. NSSC improved accuracy by 33 percentage points over BioFalcon and by 58 percentage points over scispaCy, unlocking valuable unstructured data for cancer research [26].

4.2Accelerating Clinical Trials and Drug Development

Identifying patient cohorts for clinical trials is a major bottleneck: an estimated 80% of trials miss their enrollment goals [27]. Mendel’s Hypercube platform uses a hybrid NeSy architecture that couples large language models (LLMs; neural) with a proprietary clinical hypergraph reasoning engine (symbolic) [28].

The advantage of this hybrid approach over purely LLM-based systems has been quantified. In a 2024 study on automatic cohort retrieval, Hypercube achieved an F₁ score of 62.9 on medium-complexity queries, substantially outperforming a GPT-4–based retrieval system, which scored 20.8 [29, 30]. The size of this gap suggests that combining neural perception with symbolic reasoning can be far more effective for complex clinical tasks than neural perception alone (Table 3), although independent replication is needed: Mendel co-developed the benchmark, and its reference cohorts were derived with Hypercube.

Table 3. Neurosymbolic AI in clinical practice: selected use cases and reported performance.

Application area: Precision diagnostics
NeSy system: Logical Neural Networks (LNNs)
Task: Diabetes prediction from patient features
Metric: Accuracy
Reported result: 80.52% (vs. 76.95% for random forest)
Source: [25]

Application area: Oncology research
NeSy system: Neuro-Symbolic System for Cancer (NSSC)
Task: Named entity recognition and linking from clinical notes
Metric: Accuracy
Reported result: +33 pp vs. BioFalcon; +58 pp vs. scispaCy
Source: [26]

Application area: Clinical trial cohort identification
NeSy system: Mendel Hypercube
Task: Automatic cohort retrieval (medium-complexity queries)
Metric: F₁ score
Reported result: 62.9 (vs. 20.8 for a GPT-4–based system)
Source: [29]

Application area	NeSy system	Task	Metric	Reported result	Source
Precision diagnostics	Logical Neural Networks (LNNs)	Diabetes prediction from patient features	Accuracy	80.52% (vs. 76.95% for random forest)	[25]
Oncology research	Neuro-Symbolic System for Cancer (NSSC)	Named entity recognition and linking from clinical notes	Accuracy	+33 pp vs. BioFalcon; +58 pp vs. scispaCy	[26]
Clinical trial cohort identification	Mendel Hypercube	Automatic cohort retrieval (medium-complexity queries)	F₁ score	62.9 (vs. 20.8 for a GPT-4–based system)	[29]

pp, percentage points. Results are as reported by the cited studies and are not directly comparable across rows.

5Breaking Historical Trade-Offs: Advantages and Persisting Challenges

5.1Transcending the Interpretability–Power Divide

Neurosymbolic AI is designed to break the historical trade-off in AI development, achieving both interpretability and flexibility (Figure 2).

Figure 2. Breaking the historical trade-off. Traditional symbolic systems were transparent but rigid, whereas deep neural networks are powerful but opaque. Neurosymbolic AI targets both interpretability and flexibility, learning adaptively while reasoning explicitly.Conceptual illustration: positions are qualitative and are not derived from quantitative measurements.

5.2Bias and Engineering Challenges

Algorithmic bias is a critical threat. In a neurosymbolic system, bias can enter through the neural component, for example through unrepresentative training data that overrepresent some populations and geographic regions while underrepresenting others [31, 32], and through the symbolic component, for example through human-curated knowledge graphs that encode social biases or contain gaps [33]. This dual exposure requires dedicated mitigation strategies.

Despite its advantages, NeSy faces significant engineering hurdles. The knowledge-engineering burden is high: constructing and maintaining high-quality medical knowledge graphs requires intensive manual effort [14, 34, 35]. Furthermore, the integration complexity of aligning a probabilistic neural network with a deterministic logic engine is non-trivial and affects scalability [17].

5.3Regulatory and Ethical Vigilance

Bringing NeSy-based medical devices to market requires navigating a complex regulatory landscape, including the total product life cycle approach of the U.S. Food and Drug Administration (FDA) to AI-enabled devices [36]. NeSy poses a distinctive validation challenge, because regulators must scrutinize both the statistical performance of the neural component and the logical correctness of the symbolic component.

To manage this, developers can draw on frameworks such as FUTURE-AI [37], an international consensus guideline built on six principles that include fairness, traceability, and explainability (Table 4). The inherent transparency of NeSy makes it well suited to these stringent requirements, which may ease regulatory review relative to opaque deep learning alternatives [38].

Table 4. The FUTURE-AI guiding principles for trustworthy AI in healthcare. Adapted from Lekadir et al. [37].

Principle: Fairness
Definition: AI tools should maintain consistent performance across individuals and population groups.

Principle: Universality
Definition: Solutions should be generalizable beyond the controlled environments in which they were developed.

Principle: Traceability
Definition: The AI life cycle should be completely documented and monitored.

Principle: Usability
Definition: Tools should be usable efficiently and safely in real-world clinical settings.

Principle: Robustness
Definition: Performance should remain stable under expected or unexpected variations in input data.

Principle: Explainability
Definition: Systems should provide clinically meaningful explanations for their decisions.

Principle	Definition
Fairness	AI tools should maintain consistent performance across individuals and population groups.
Universality	Solutions should be generalizable beyond the controlled environments in which they were developed.
Traceability	The AI life cycle should be completely documented and monitored.
Usability	Tools should be usable efficiently and safely in real-world clinical settings.
Robustness	Performance should remain stable under expected or unexpected variations in input data.
Explainability	Systems should provide clinically meaningful explanations for their decisions.

6Future Transformation: Strategic Research Agenda and Clinical Translation

As neurosymbolic AI matures, it is poised to evolve from a promising collection of techniques into a foundational pillar of next-generation intelligent medicine.

6.1Beyond Pattern Matching: The Quest for Causality

The fusion of causal inference with neurosymbolic architectures (causal NeSyAI) is a highly promising path toward causal reasoning [39]. By explicitly representing causal relationships in its symbolic component, a NeSy system can help clinicians reason about the effects of interventions (rung two) and even counterfactuals (rung three) on Judea Pearl’s ladder of causation [40, 41].

6.2A Symbiotic Future with Foundation Models

A pragmatic path forward lies in the emerging neurosymbolic prompting paradigm, abbreviated PrSy (prompt-symbolic) by Stein et al. [42]. This approach uses large pretrained language models for the perception task (extracting information from unstructured clinical notes) and passes the structured output to a deterministic symbolic program for the reasoning task (verifying facts against a clinical database or applying a diagnostic algorithm). In the near term, this modular hybrid design is likely the most scalable and practical implementation of the neurosymbolic philosophy.

6.3A 2030 Roadmap for Neurosymbolic Healthcare

The global market for AI in healthcare is projected to grow rapidly, surpassing US$187 billion by 2030 [43], and NeSy is well placed to capture a significant share of the value in high-trust applications.

Predictive and personalized care. AI systems will routinely integrate electronic health records (EHRs), genomic data, and social determinants of health to generate personalized risk predictions [44], with a neurosymbolic core providing a transparent, evidence-based explanation for every recommendation.
Networked hospitals and efficient operations. NeSy systems will be critical for optimizing complex logistics, enforcing clinical pathways, and reducing clinicians’ administrative burden by automating documentation with verifiable accuracy [44].
The clinician’s AI partner. The most profound transformation will occur in clinicians’ daily workflows. A neurosymbolic AI partner will become a standard tool, capable of instantly summarizing a patient’s entire history, flagging risks, suggesting differential diagnoses, and transparently displaying the chain of reasoning it followed [10, 45].

Figure 3 outlines the research milestones required to realize this vision.

1
Years 1–2Foundational infrastructure
- Develop standardized benchmarks with multimodal clinical data and causal annotations
- Create open-source frameworks for differentiable symbolic reasoning layers
- Establish evaluation protocols beyond traditional machine learning metrics
2
Years 2–3Advanced capabilities
- Design scalable, interpretable counterfactual inference engines
- Integrate large medical knowledge graphs with neural architectures
- Develop uncertainty quantification methods for hybrid systems
3
Years 4–5Clinical translation
- Establish governance frameworks for versioning and validation
- Conduct prospective clinical trials in controlled settings
- Define regulatory pathways for hybrid AI medical devices

Figure 3. Strategic five-year research roadmap: technical building blocks and translational milestones required for the safe clinical deployment of neurosymbolic healthcare AI systems.Phases overlap where work streams are expected to run in parallel.

7The Future of Truly Intelligent Healthcare

Soon, a physician facing a complex case will consult an AI partner that reasons aloud: “Given the patient’s fever, joint pain, and rash, combined with recent travel to an endemic region and low platelet and white blood cell counts, dengue fever best fits both the statistical evidence and the established clinical criteria. However, chikungunya remains a key differential diagnosis; I recommend NS1 antigen and serological testing to distinguish between them.” The physician reviews this logic, validates the evidence, and refines the plan [10, 45]. This is collaboration, not automation.

This symbiotic partnership, built on a foundation of explainable and verifiable reasoning, is the ultimate promise of the neurosymbolic third wave. By shouldering the cognitive load of data synthesis and rule-based analysis, trustworthy AI partners will free clinicians to focus on the uniquely human aspects of medicine: empathy, complex ethical judgment, and the patient–physician relationship. The goal is not to create an artificial doctor but to empower human doctors to practice medicine at the highest level of their ability.

How to Cite

APA

Costilla Reyes, O. (2025, October 20). Neurosymbolic artificial intelligence in healthcare: From foundations to future transformation. Equ Healthcare Research Articles. https://blog.equ.care/blog/neurosymbolic-ai-healthcare

BibTeX

@misc{costilla2025neurosymbolic,
  author       = {Costilla Reyes, Omar},
  title        = {Neurosymbolic Artificial Intelligence in Healthcare:
                  From Foundations to Future Transformation},
  year         = {2025},
  month        = oct,
  howpublished = {Equ Healthcare Research Articles},
  url          = {https://blog.equ.care/blog/neurosymbolic-ai-healthcare}
}

References

[1]McKinney, S. M., Sieniek, M., Godbole, V., et al. (2020). International evaluation of an AI system for breast cancer screening. Nature, 577(7788), 89–94.
[2]Hyland, S. L., Faltys, M., Hüser, M., et al. (2020). Early prediction of circulatory failure in the intensive care unit using machine learning. Nature Medicine, 26(3), 364–373.
[3]Campanella, G., Hanna, M. G., Geneslaw, L., et al. (2019). Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nature Medicine, 25(8), 1301–1309.
[4]Simbo AI (n.d.). The historical development of artificial intelligence in healthcare: From MYCIN to modern applications and future directions. Simbo AI Blog. Retrieved October 7, 2026.
[5]Shortliffe, E. H., & Buchanan, B. G. (1975). A model of inexact reasoning in medicine. Mathematical Biosciences, 23(3–4), 351–379.
[6]McCarthy, J. (1984). Some expert systems need common sense. Annals of the New York Academy of Sciences, 426, 129–137. https://doi.org/10.1111/j.1749-6632.1984.tb16516.x
[7]Gulshan, V., Peng, L., Coram, M., et al. (2016). Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA, 316(22), 2402–2410.
[8]Esteva, A., Kuprel, B., Novoa, R. A., et al. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115–118.
[9]Rajpurkar, P., Irvin, J., Zhu, K., et al. (2017). CheXNet: Radiologist-level pneumonia detection on chest X-rays with deep learning. arXiv preprint arXiv:1711.05225.
[10]Galil, K. (2025). How neuro-symbolic AI bridges the trust gap for physicians. Medical Economics.
[11]Rudin, C. (2019). Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nature Machine Intelligence, 1(5), 206–215.
[12]Newell, A., & Simon, H. A. (1976). Computer science as empirical inquiry: Symbols and search. Communications of the ACM, 19(3), 113–126.
[13]Turner, J. (2023). AI milestone series, episode 4: Introduction of expert systems (1970s–1980s). AI Mind.
[14]Attoresi, M. (2024). Neuro-symbolic artificial intelligence. European Data Protection Supervisor, TechSonar Report 2025.
[15]Upside Staff (2024). Q&A: Can neuro-symbolic AI solve AI's weaknesses? TDWI, Interview with J. Aasman.
[16]LeCun, Y., Bengio, Y., & Hinton, G. (2015). Deep learning. Nature, 521(7553), 436–444.
[17]Orakzai, R. U. (2025). Neurosymbolic AI explained. Baeldung on Computer Science.
[18]Fahim, Y. A., Hasani, I. W., Kabba, S., & Ragab, W. M. (2025). Artificial intelligence in healthcare and medicine: Clinical applications, therapeutic advances, and future perspectives. European Journal of Medical Research, 30, 848.
[19]Hossain, D., & Chen, J. Y. (2025). A study on neuro-symbolic artificial intelligence: Healthcare perspectives. arXiv preprint arXiv:2503.18213.
[20]Ji, Z., Lee, N., Frieske, R., et al. (2023). Survey of hallucination in natural language generation. ACM Computing Surveys, 55(12), 248.
[21]Prabhakar, A. V. (2025). Neuro-symbolic AI for multimodal reasoning: Foundations, advances, and emerging applications. ajithp.com.
[22]Bougzime, O., Jabbar, S., Cruz, C., & Demoly, F. (2025). Unlocking the potential of generative AI through neuro-symbolic architectures: Benefits and limitations. arXiv preprint arXiv:2502.11269.
[23]Kahneman, D. (2011). Thinking, fast and slow. Farrar, Straus and Giroux.
[24]Kautz, H. (2022). The third AI summer: AAAI Robert S. Engelmore Memorial Lecture. AI Magazine, 43(1), 105–125.
[25]Lu, Q., Li, R., Sagheb, E., et al. (2025). Explainable diagnosis prediction through neuro-symbolic integration. AMIA Joint Summits on Translational Science Proceedings, 2025, 332–341. PMID: 40502272.
[26]García-Barragán, Á., Sakor, A., Vidal, M.-E., et al. (2025). NSSC: A neuro-symbolic AI system for enhancing accuracy of named entity recognition and linking from oncologic clinical notes. Medical & Biological Engineering & Computing, 63(3), 749–772.
[27]Meta AI (2025). Dramatically accelerating patient-matching in clinical trials with open source. Meta AI Blog.
[28]Mendel (2024). Mendel unveils groundbreaking neuro-symbolic AI system outperforming GPT-4 for automatic cohort retrieval in new study. Business Wire, Press release, July 2, 2024.
[29]Thai, D. N., Ardulov, V., Mena, J. U., et al. (2024). ACR: A benchmark for automatic cohort retrieval. arXiv preprint arXiv:2406.14780.
[30]Napitupulu, J. (2024). Mendel's AI system outperforms GPT-4 in patient cohort identification. Clinical Trial Vanguard.
[31]Ganapathi, S., Palmer, J., Alderman, J. E., et al. (2022). Tackling bias in AI health datasets through the STANDING Together initiative. Nature Medicine, 28(11), 2232–2233.
[32]Cross, J. L., Choma, M. A., & Onofrey, J. A. (2024). Bias in medical AI: Implications for clinical decision-making. PLOS Digital Health, 3(11), e0000651.
[33]Kraft, A., & Usbeck, R. (2022). The lifecycle of “facts”: A survey of social bias in knowledge graphs. Proceedings of the 2nd Conference of the Asia-Pacific Chapter of the ACL and the 12th International Joint Conference on Natural Language Processing (AACL-IJCNLP), pp. 639–652.
[34]Hogan, A., Blomqvist, E., Cochez, M., et al. (2021). Knowledge graphs. ACM Computing Surveys, 54(4), 71.
[35]Holi, L. (2025). Neuro-symbolic AI: The key to safe and reliable AI in high-risk sectors. Medium.
[36]U.S. Food and Drug Administration (n.d.). Artificial intelligence-enabled medical devices. FDA Digital Health Center of Excellence. Retrieved October 7, 2026.
[37]Lekadir, K., Frangi, A. F., Porras, A. R., et al. (2025). FUTURE-AI: International consensus guideline for trustworthy and deployable artificial intelligence in healthcare. BMJ, 388, e081554.
[38]Orzechowski, P. (2025). Moving towards clinically validated neuro-symbolic AI. Infermedica Blog.
[39]Jaimini, U., Henson, C., & Sheth, A. (2024). Causal neurosymbolic AI: A synergy between causality and neurosymbolic methods. IEEE Intelligent Systems, 39(3), 13–19.
[40]Pearl, J., & Mackenzie, D. (2018). The book of why: The new science of cause and effect. Basic Books.
[41]Jaimini, U. (2025). Causal neurosymbolic AI [PhD dissertation defense]. AI Institute at the University of South Carolina, YouTube.
[42]Stein, A., Naik, A., Velingker, N., et al. (2025). The road to generalizable neuro-symbolic learning should be paved with foundation models. arXiv preprint arXiv:2505.24874.
[43]Lawal, L. (2025). Why strategy beats speed in introducing AI for healthcare. World Economic Forum.
[44]Kriwet, C. (2020). Here are 3 ways AI will change healthcare by 2030. World Economic Forum.
[45]KPMG LLP (2025). Intelligent healthcare: A blueprint for creating value through AI-driven transformation. KPMG.

About the author

Dr. Omar Costilla Reyes is Founder and CEO of Equ Healthcare, where he leads research and product work on explainable AI for health. His research spans explainable machine learning, digital phenotyping, neurosymbolic program synthesis and computational neuroscience, building on research appointments across neuroscience, medical engineering and computer science at MIT. Read his full profile.